• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
New antiviral may offer ‘less cumbersome’ COVID treatment option

New antiviral may offer ‘less cumbersome’ COVID treatment option

The Chinese-developed oral antiviral reportedly achieves similar outcomes to Paxlovid, but with fewer side effects and drug–drug interactions.


RACGP pushes for greater reproductive healthcare access

RACGP pushes for greater reproductive healthcare access

A college submission has called for changes aimed at making abortion and contraceptive services more affordable and accessible.


Molnupiravir to be used only as a last resort: Taskforce

Molnupiravir to be used only as a last resort: Taskforce

Advice has changed for the country’s most prescribed COVID-19 oral antiviral, although access via the PBS will remain in place.


Second bivalent booster receives ATAGI recommendation

Second bivalent booster receives ATAGI recommendation

The vaccine will become available in December and is recommended for people who have not had their first or second booster doses.


‘A positive step’: oral antivirals confirmed for Doctor’s Bag

‘A positive step’: oral antivirals confirmed for Doctor’s Bag

After extensive RACGP lobbying, GPs now have enhanced access to COVID-19 oral antiviral treatments for urgent use among at-risk patients.
 


Oral antivirals access opens to more Aboriginal Australians

Oral antivirals access opens to more Aboriginal Australians

The move will come in with PBS changes from 1 November, which also include a treatment for a rare genetic disease.  


Enhanced antivirals access a victory for patients

Enhanced antivirals access a victory for patients

RACGP Vice President Dr Bruce Willett goes behind the scenes of a successful campaign to help GPs supply oral antivirals to at-risk patients.


Push to allow pharmacist prescribing of antivirals flipped on its head

Push to allow pharmacist prescribing of antivirals flipped on its head

A ‘more sensible approach’ would see the lifesaving medications added to the Doctor’s Bag, a prominent GP has said.


Could anticipatory deprescribing allow better COVID treatment?

Could anticipatory deprescribing allow better COVID treatment?

Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.


Push to assess COVID-19 treatment eligibility prior to infection

Push to assess COVID-19 treatment eligibility prior to infection

College launches new guidelines to support GPs assessing the best approach for vulnerable patients before they test positive.


  • Previous
  • ...
  • 4
  • 5
  • 6
  • ...
  • Next
Pages: 4 of 7
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807